Corona Remedies P/E Ratio

Current P/E Ratio

64.87

High Valuation

Very High - High growth expectations or significantly overvalued

Corona Remedies (CORONA) P/E ratio is 64.87 (High), EPS (TTM) ₹30.27, current price ₹2037.90 on NSE vs historical average P/E of 51.35 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Read CORONA dividend track record for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/E Ratio 64.87

Current Price ₹2037.90

EPS (TTM) ₹30.27

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 51.35

Historical Range 51.35 - 51.35

Percentile 100.0%

Sector Context

Sector Average 54.74

Sector Median 31.04

Sector Rank #11 of 194

Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹28.67

Mar 2026 ₹7.41

Sept 2025 ₹8.55

CORONA P/E Ratio — Valuation Signal & Historical Context

Corona Remedies P/E 64.87 vs historical average 51.35, range 51.35–51.35 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Corona Remedies stock price NSE.

Stock appears overvalued with PE of 64.87, suggesting caution for new investments
Current PE is 26.3% above historical average
Trading at premium to sector average PE of 54.74

Corona Remedies P/E Ratio Historical Trend

CORONA annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 64.87 vs historical average 51.35. See CORONA P/B ratio history to compare market price against book value per share.

CORONA Historical P/E Ratio — EPS, Year-End Price & Valuation

Corona Remedies annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	51.35	28.01	₹1438.40	NSE	High

CORONA vs Healthcare Peers — P/E Ratio Comparison

Corona Remedies P/E 64.87 vs Healthcare average 54.74, median 31.04 — range 2.86–950.0.

Sector Average

54.74

Sector Median

31.04

Lowest P/E

2.86

Highest P/E

950.0

Companies

194

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Murae Organisor	MURAE	2.86	₹41	Low
Sunrest Lifescience	SUNREST	3.65	₹29	Low
Phaarmasia	PHRMASI	3.89	₹69	Low
JFL Life Sciences	JFLLIFE	4.64	₹59	Low
Sun Pharma Advanced Rese…	SPARC	4.69	₹7,502	Low
Shelter Pharma	SHELTER	5.32	₹50	Low
Mono Pharmacare	MONOPHARMA	6.02	₹19	Low
Royal Sense	ROYAL	7.4	₹51	Low
Zenith Drugs	ZENITHDRUG	7.69	₹79	Low
Amwill Health Care	AMWILL	7.71	₹88	Low